Resetting R&D for AI
While AI is a hot topic in every industry, the massive potential for impact within biotech — from predictive insights to shortened development time — has resulted in companies racing to unlock the potential.
Join Benchling Co-Founder & President, Ashu Singhal and Ron Hause, SVP, Head of AI, Shape Therapeutics to learn how companies are updating their approach to R&D.
In this webinar we focus on:
AI-ready data: Improving at scale generation of high-quality data for model building and fine-tuning
AI-enabled scientist: Integrating the right models directly into scientist workflows for everyday use
Scalability: Making performance, speed, privacy, and cost tradeoffs for deployment of AI, and connecting the wet and dry labs
